Companies: 10,795·Total market cap: $144.5T
Coeptis Therapeutics, Inc.

Coeptis Therapeutics, Inc.

COEPNASDAQHealthcare
$16.40
+$0.00(+0.00%)
Market Cap$57626976
P/E Ratio—
52W High$21.41
52W Low$6.8
Overview

Coeptis Therapeutics, Inc. (COEP) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · COEP · as of Mar 19, 2026

Latest filing snapshot

7
+0+0.00%vs prior year

Coeptis Therapeutics, Inc. (COEP) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
7
Change (1Y)
+0
Growth % (1Y)
+0.00%
Revenue / Employee
$194.7K
Net Income / Employee
$-1.70M
Market Cap
$58M

COEP Employee Count

2022 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-197+0+0.00%
2025-03-287+0+0.00%
2024-03-267+2+40.00%
2023-03-295——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Karyopharm Therapeutics Inc.
KPTI
Karyopharm Therapeutics Inc.
279#2
Century Therapeutics, Inc.
IPSC
Century Therapeutics, Inc.
140#3
Cue Biopharma, Inc.
CUE
Cue Biopharma, Inc.
41#4
Equillium, Inc.
EQ
Equillium, Inc.
35#5
Medicus Pharma Ltd. Common Stock
MDCX
Medicus Pharma Ltd. Common Stock
12#6
Coeptis Therapeutics, Inc.
COEP
Coeptis Therapeutics, Inc.YOU
7#7
NRx Pharmaceuticals, Inc.
NRXP
NRx Pharmaceuticals, Inc.
2
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · COEP peer comparison

About COEP employees

COEP Employees · Headcount

Coeptis Therapeutics, Inc. (COEP) employee data is sourced from the annual SEC 10-K filing. As of 2025, Coeptis Therapeutics, Inc. had 7 full-time employees globally. Full-time employees only. Global consolidated headcount.

Coeptis Therapeutics, Inc. employs 7 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $194,721, reflecting the company's operational efficiency.

Coeptis Therapeutics, Inc.'s workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Coeptis Therapeutics, Inc.'s revenue per employee of $194,721 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

COEP Employees · 5 questions

As of the latest SEC 10-K filing (2025), Coeptis Therapeutics, Inc. had 7 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Coeptis Therapeutics, Inc. employee counthow many employees does Coeptis Therapeutics, Inc. haveCOEP total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-19